A Phase II, single-arm trial of Atezolizumab/Platinum/Etoposide for the treatment of advanced large-cell neuroendocrine cancer of the lung.
Latest Information Update: 30 Sep 2024
At a glance
- Drugs Atezolizumab (Primary) ; Etoposide; Platinum complexes
- Indications Lung cancer; Neuroendocrine carcinoma
- Focus Therapeutic Use
- Acronyms LCNEC-ALPINE
- Sponsors Roche Pharma AG
- 01 Jul 2021 New trial record